|
|
|
|
Pharma and biotech developers rely on adaptable fill‑finish capacity to meet evolving market demands, scale products from clinical to commercial, and respond rapidly to public‑health emergencies.
|
|
|
|
|
Reliable, monitored cold storage keeps sensitive materials stable from fill to patient to protect their quality, prevent degradation, and ensure safety throughout the cold chain.
|
|
|
|
|
Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.
|
|
|
|
|
Annex 1 sets EU regulatory standards for sterile manufacturing, which emphasize contamination control, quality management, and risk prevention to enhance patient safety and regulatory compliance globally.
|
|
|
|
|
AI-powered predictive maintenance with wireless vibration sensors prevented batch loss and production shutdowns in manufacturing by detecting and fixing equipment issues before failures occurred.
|
|
|
|
|
We partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.
|
|
|
